PL371741A1 - Leczenie skojarzone ostrego zawału mięśnia sercowego - Google Patents
Leczenie skojarzone ostrego zawału mięśnia sercowegoInfo
- Publication number
- PL371741A1 PL371741A1 PL03371741A PL37174103A PL371741A1 PL 371741 A1 PL371741 A1 PL 371741A1 PL 03371741 A PL03371741 A PL 03371741A PL 37174103 A PL37174103 A PL 37174103A PL 371741 A1 PL371741 A1 PL 371741A1
- Authority
- PL
- Poland
- Prior art keywords
- myocardial infarction
- acute myocardial
- combination treatment
- combination
- treatment
- Prior art date
Links
- 206010000891 acute myocardial infarction Diseases 0.000 title abstract 3
- 238000011284 combination treatment Methods 0.000 title 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 abstract 1
- 229960000692 levosimendan Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960000103 thrombolytic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020197A FI20020197A0 (fi) | 2002-02-01 | 2002-02-01 | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL371741A1 true PL371741A1 (pl) | 2005-06-27 |
| PL212241B1 PL212241B1 (pl) | 2012-08-31 |
Family
ID=8563019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL371741A PL212241B1 (pl) | 2002-02-01 | 2003-01-31 | Złożony produkt leczniczy i jego zastosowanie |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050255096A1 (pl) |
| EP (1) | EP1478362B1 (pl) |
| JP (1) | JP2005516050A (pl) |
| CN (1) | CN1291718C (pl) |
| AT (1) | ATE306267T1 (pl) |
| AU (1) | AU2003201980B2 (pl) |
| BR (1) | BR0307317A (pl) |
| CA (1) | CA2474430C (pl) |
| DE (1) | DE60301862T2 (pl) |
| DK (1) | DK1478362T3 (pl) |
| ES (1) | ES2249707T3 (pl) |
| FI (1) | FI20020197A0 (pl) |
| IL (1) | IL163091A (pl) |
| MX (1) | MXPA04007345A (pl) |
| NZ (1) | NZ534221A (pl) |
| PL (1) | PL212241B1 (pl) |
| WO (1) | WO2003063870A1 (pl) |
| ZA (1) | ZA200406085B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
| FI20040674A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
| WO2006087420A2 (en) * | 2005-02-18 | 2006-08-24 | Orion Corporation | A method for treating heart failure |
| US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| US9375440B2 (en) * | 2006-11-03 | 2016-06-28 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| WO2008082871A1 (en) * | 2006-12-28 | 2008-07-10 | Orion Corporation | Formulations of levosimendan for parenteral administration |
| AU2013205148B2 (en) * | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
| EP4076398B1 (en) | 2019-12-16 | 2026-02-18 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hf-pef) |
| CN115518037A (zh) * | 2022-10-14 | 2022-12-27 | 上药东英（江苏）药业有限公司 | 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法 |
| JP2026500565A (ja) | 2022-12-27 | 2026-01-07 | アヴィータ・メディカル・アメリカズ，リミテッド・ライアビリティ・カンパニー | 再生上皮懸濁液の自動調製のためのシステムおよび関連する使用方法 |
| US12570949B2 (en) | 2022-12-27 | 2026-03-10 | AVITA Medical Americas, LLC | Systems and devices for wound therapy and related methods of use |
| USD1112812S1 (en) | 2023-12-22 | 2026-02-10 | AVITA Medical Americas, LLC | Tissue processing cartridge |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972990A (en) * | 1992-04-10 | 1999-10-26 | Brigham And Women's Hospital, Inc. | Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
| GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| US5626601A (en) * | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
| US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| US5463564A (en) * | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
-
2002
- 2002-02-01 FI FI20020197A patent/FI20020197A0/fi unknown
-
2003
- 2003-01-31 CN CNB038030918A patent/CN1291718C/zh not_active Expired - Fee Related
- 2003-01-31 JP JP2003563560A patent/JP2005516050A/ja active Pending
- 2003-01-31 AT AT03700828T patent/ATE306267T1/de active
- 2003-01-31 BR BR0307317-3A patent/BR0307317A/pt not_active Application Discontinuation
- 2003-01-31 ES ES03700828T patent/ES2249707T3/es not_active Expired - Lifetime
- 2003-01-31 DE DE60301862T patent/DE60301862T2/de not_active Expired - Lifetime
- 2003-01-31 EP EP03700828A patent/EP1478362B1/en not_active Expired - Lifetime
- 2003-01-31 MX MXPA04007345A patent/MXPA04007345A/es active IP Right Grant
- 2003-01-31 US US10/502,981 patent/US20050255096A1/en not_active Abandoned
- 2003-01-31 CA CA2474430A patent/CA2474430C/en not_active Expired - Fee Related
- 2003-01-31 NZ NZ534221A patent/NZ534221A/xx not_active IP Right Cessation
- 2003-01-31 PL PL371741A patent/PL212241B1/pl not_active IP Right Cessation
- 2003-01-31 DK DK03700828T patent/DK1478362T3/da active
- 2003-01-31 AU AU2003201980A patent/AU2003201980B2/en not_active Ceased
- 2003-01-31 WO PCT/FI2003/000078 patent/WO2003063870A1/en not_active Ceased
-
2004
- 2004-07-19 IL IL163091A patent/IL163091A/en not_active IP Right Cessation
- 2004-07-29 ZA ZA200406085A patent/ZA200406085B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1478362A1 (en) | 2004-11-24 |
| IL163091A (en) | 2012-06-28 |
| DE60301862T2 (de) | 2006-07-20 |
| CN1625398A (zh) | 2005-06-08 |
| ATE306267T1 (de) | 2005-10-15 |
| ES2249707T3 (es) | 2006-04-01 |
| DE60301862D1 (de) | 2006-02-23 |
| WO2003063870A1 (en) | 2003-08-07 |
| US20050255096A1 (en) | 2005-11-17 |
| CA2474430A1 (en) | 2003-08-07 |
| MXPA04007345A (es) | 2004-11-26 |
| JP2005516050A (ja) | 2005-06-02 |
| CN1291718C (zh) | 2006-12-27 |
| ZA200406085B (en) | 2005-10-06 |
| DK1478362T3 (da) | 2005-11-14 |
| AU2003201980B2 (en) | 2006-12-07 |
| BR0307317A (pt) | 2005-01-04 |
| HK1077215A1 (en) | 2006-02-10 |
| EP1478362B1 (en) | 2005-10-12 |
| NZ534221A (en) | 2007-06-29 |
| FI20020197A0 (fi) | 2002-02-01 |
| PL212241B1 (pl) | 2012-08-31 |
| CA2474430C (en) | 2010-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200107920B (en) | Apomorphine and sildenafil composition. | |
| AU1249902A (en) | Effective antitumour treatments | |
| CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
| PL371741A1 (pl) | Leczenie skojarzone ostrego zawału mięśnia sercowego | |
| TW200616608A (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| GB0020504D0 (en) | Therapeutic method | |
| FI20011464A0 (fi) | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon | |
| TW200509909A (en) | Use of organic compounds | |
| PT1534296E (pt) | UTILIZAÇÃO DE CILOBRADINA OU DOS SEUS SAIS FARMACEUTICAMENTE ACEITÁVEIS PARA O TRATAMENTO OU PREVENÇÃO DA INSUFICIjNCIA CARDÍACA | |
| AU2001236529A1 (en) | Combination therapy for cancer | |
| IL159770A0 (en) | Calcium salts with cytotoxic activity | |
| AU4258601A (en) | Divided dose therapies with vascular damaging activity | |
| EP1347754A4 (en) | COMPOSITIONS FOR PREVENTION OF ADHESION | |
| ATE464051T1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
| UA36576A (uk) | Спосіб корекції реактивності організму у хворих на інфаркт міокарда в гострому та підгострому періодах | |
| PL372986A1 (pl) | Zastosowanie dewazepidu jako leku przeciwbólowego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20130131 |